Release Details

A scientist inside the laboratory testing specimens

Biogen to Participate in the Stifel 2024 Virtual CNS Days

March 12, 2024

Cambridge, MA, - - Biogen Inc (Nasdaq: BIIB) announced today that Priya Singhal, M.D., M.P.H., Head of Development, will participate in a fireside chat during the Stifel 2024 Virtual CNS Days. The webcast will be live on Tuesday, March 19, 2024, at 10:00 a.m. ET. To access the live webcast, please visit the Investors section of Biogen’s website at An archived version of the webcast will be available for at least 30 days following the presentation.

About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.

We routinely post information that may be important to investors on our website at Follow us on social media - Facebook, LinkedIn, X, YouTube.

Karen Jewell
Investor Releations

Stockholder Communications icon

Stockholder Communications

E-mail Alerts icon

E-mail Alerts

FAQs icon